Insider Transactions Reported by 25 Insiders of Apellis Pharmaceuticals, Inc.

Symbol
APLS on Nasdaq
Location
Waltham, MA

Insiders trading volume in the past year

Apellis Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Morningside Venture Investments Ltd 10%+ Owner $815,635,922 18 Nov 2021
Cedric Francois Chief Executive Officer, Director $39,673,844 -$10,419,501 -21% 27 Aug 2025
Alec Machiels Director $11,308,438 01 Jan 2025
LUKAS SCHEIBLER Chief Research Officer $6,961,586 01 Dec 2023
Timothy Sullivan Chief Financial Officer $6,075,972 -$1,694,615 -22% 21 Oct 2025
Federico Grossi Chief Medical Officer $6,043,162 05 Jan 2023
Pascal Deschatelets Chief Scientific Officer $5,963,139 -$232,645 -3.8% 09 Jun 2025
David Watson General Counsel $5,350,559 -$1,794,406 -25% 16 Dec 2025
Caroline Baumal Chief Medical Officer $4,394,816 -$150,727 -3.3% 09 Jun 2025
Nur Nicholson Chief Technical Officer $4,069,737 -$284,281 -6.5% 09 Jun 2025
Mark DeLong Chief Business & Strat Officer $3,995,365 -$146,503 -3.5% 09 Jun 2025
Kelley Boucher Chief People Officer $3,624,232 02 Sep 2025
Sinclair Dunlop Director $3,476,103 -$2,153,155 -38% 30 Sep 2025
Adam Townsend Chief Commercial Officer $2,481,459 -$264,626 -9.6% 29 Jan 2025
Karen Lewis Chief People Officer $2,074,062 -$147,094 -6.6% 29 Jan 2025
Jeffrey Eisele Chief Development Officer $1,633,009 -$55,064 -3.3% 29 Jan 2025
James Chopas VP/Chief Accounting Officer $1,511,634 -$101,741 -6.3% 15 Sep 2025
Victoria Brown Program Team Lead $1,500,282 20 Jan 2023
LESLIE MELTZER Chief Research and Development $1,171,185 26 Aug 2025
CRAIG A. WHEELER Director $873,632 17 Apr 2025
Keli Walbert Director $815,155 08 Jan 2025
Nicole Perry Vice President - Accounting $717,179 02 Aug 2021
PAUL R. FONTEYNE Director $695,556 01 Jan 2025
Gerald Chan Director $626,306 01 Jan 2025
Stephanie O'Brien Director $626,306 01 Jan 2025

Recent Insider Transactions by Companies or Individuals for Apellis Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.